Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options, Valuation Assumptions

The following table provides the weighted average assumptions used in determining the fair value of the stock options granted during the years ended December 31, 2022 and December 31, 2021:

 

    December 31, 2022     December 31, 2021  
       
Risk-free interest rate     1.75 %     0.79 %
Expected life     6.0 years       6.0 years  
Expected volatility     129.88 %     134.73 %
Dividend yield     -       -  
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award

Stock-based compensation from continuing operations for the years ended December 31, 2022 and 2021 is as follows: 

 

    2022     2021  
RSUs and restricted stock   $ 498     $ 370  
Performance-based awards     71       107  
Options     622       555  
Total stock-based compensation expense   $ 1,191     $ 1,032  
Schedule of Stock Option Activity

A summary of stock option activity for the year ended December 31, 2022, and changes during such year, is presented below:

 

 Schedule of Stock Option Activity

          Weighted-     Weighted-Average        
          Average     Remaining     Aggregate  
          Grant     Contractual     Intrinsic  
    Shares     Price     Period (in years)     Value  
Outstanding at January 1, 2022     632,511     $ 6.89       8.40     $                   -  
Granted     41,000       5.03       9.01       -  
Forfeited or expired     (145,667 )     7.91       -       -  
Outstanding at December 31, 2022     527,844       6.46       7.57       -  
                                 
Exercisable at December 31, 2022     270,080       7.39       7.16       -  
                                 
Vested and expected to vest     518,511       6.47       7.55       -  
Schedule of Non Vested Option Activity

A summary of the change in of the Company’s non-vested options for the year ended December 31, 2022 is presented below: 

 

    Shares     Weighted- Average Grant Date Fair Value  
             
Nonvested at January 1, 2022     422,476     $ 4.78  
Granted     41,000       4.50  
Vested     (142,709 )     5.02  
Forfeited     (63,003 )     4.69  
Nonvested at December 31, 2022     257,764     $ 4.63  
Schedule of Share-Based Compensation, Restricted Stock and Restricted Stock Units Activity

A summary of the Company’s non-vested shares of restricted stock and restricted stock units for the year ended December 31, 2022, and changes during such year, is presented below:

 

          Weighted-     Average        
          Average     Remaining     Aggregate  
          Grant Date     Vesting     Intrinsic  
    Shares     Fair Value     Period (in years)     Value  
Nonvested at January 1, 2022     328,939     $ 3.67       1.34     $ 2,467,043  
Granted     74,000       6.18       -       -  
Vested     (113,932 )     4.88       -       -  
Forfeited     (40,002 )     6.15       -       -  
Nonvested at December 31, 2022     249,005     $ 3.47       0.98     $ 258,965